Advanced Search

Psychiatry Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

HEADS OF FACULTY

  • Photo of Julien Mendlewicz

    Julien Mendlewicz

    School of Medicine, University of Brussels, Dworp-Beersel, Belgium

  • Photo of Judith Rapoport

    Judith Rapoport

    Child Psychiatry Branch, National Institute of Mental Health, Bethesda, MD, USA

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

10
[CONFERENCE POSTER]: Stress exposure produces a switch from appetitive to aversive signaling by corticotropin-releasing factor in the nucleus accumbens.

Lemos J, Wanat M, Smith J, Reyes B, Van Bockstaele E, Chavkin C, Phillips P. F1000 Posters Based on: 50th Annual Meeting of the American College of Neuropsychopharmacology. 2012:51

1 Evaluation, most recent by

Friedbert Weiss, The Scripps Research Institute, USA. F1000 Psychiatry

Past 7 Days

22

New Evaluations

5,333 total

9

New Articles Evaluated

2,994 total

Past 30 Days

INDIVIDUALS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.

Get a FREE Trial Subscribe for $9.95 per month

Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.

RECOMMENDATIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

LIBRARIANS & INFORMATION MANAGERS

Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.

Request an Institutional Trial

FREE ACCESS

Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.